vimarsana.com

Latest Breaking News On - Calithera biosciences - Page 18 : vimarsana.com

Calithera Biosciences (NASDAQ:CALA) Earns Hold Rating from Analysts at StockNews com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a research report released on Tuesday morning. The firm issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance Shares of CALA opened at $0.36 on Tuesday. Calithera Biosciences has a one year low of $0.01 and a one […]

Carver Bancorp (NASDAQ:CARV) Receives New Coverage from Analysts at StockNews com

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a report released on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance NASDAQ CALA opened at $0.36 on Tuesday. The stock has a market capitalization of $1.75 million, a P/E ratio of -0.01 and […]

Calithera Biosciences (NASDAQ:CALA) Now Covered by StockNews com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a report released on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance Shares of Calithera Biosciences stock opened at $0.36 on Tuesday. The company has a market capitalization of $1.75 million, a PE ratio […]

Investment Analysts New Coverage for May 30th (AEZS, AIRG, BAM, BIOC, BSX, CALA, CCLP, CFLT, COO, CRSP)

Investment Analysts’ new coverage for Tuesday, May 30th: StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS) (TSE:AEZ). The firm issued a sell rating on the stock. StockNews.com assumed coverage on shares of Airgain (NASDAQ:AIRG). StockNews.com issued a buy rating on the stock. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Brookfield Asset Management (NYSE:BAM) […]

Calithera Biosciences (NASDAQ:CALA) Coverage Initiated by Analysts at StockNews com

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a research note released on Monday. The firm issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance NASDAQ CALA opened at $0.33 on Monday. The stock has a market capitalization of $1.61 million, a PE ratio of -0.01 […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.